Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

This study has been completed.
Sponsor:
Information provided by:
German CLL Study Group
ClinicalTrials.gov Identifier:
NCT00274963
First received: January 10, 2006
Last updated: September 30, 2016
Last verified: September 2016